Načítá se...
Inhibition of the Mechanistic Target of Rapamycin (mTOR)–Rapamycin and Beyond
Rapamycin is a Food and Drug Administration (FDA)-approved immunosuppressant and anticancer agent discovered in the soil of Easter Island in the early 1970s. Rapamycin is a potent and selective inhibitor of the mechanistic target of rapamycin (mTOR) protein kinase, which acts as a central integrator...
Uloženo v:
| Vydáno v: | Cold Spring Harb Perspect Med |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cold Spring Harbor Laboratory Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4852795/ https://ncbi.nlm.nih.gov/pubmed/27048303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a025924 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|